QCM
RCUS icon

Quantinno Capital Management’s Arcus Biosciences RCUS Stock Holding History

Quantinno Capital Management’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.77M Buy
57,255
+39,960
+231% +$988K ﹤0.01% 2080
2026
Q1 		$374K Buy
17,295
+1,349
+8% +$29.1K ﹤0.01% 2913
2025
Q4 		$380K Buy
15,946
+735
+5% +$15K ﹤0.01% 2668
2025
Q3 		$207K Buy
+15,211
New +$158K ﹤0.01% 2744

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Quantinno Capital Management's RCUS Position: Q2 2026 in Review

Quantinno Capital Management increased its Arcus Biosciences (RCUS) stake by 231% in Q2 2026, buying an estimated $988K and bringing the position to 57,255 shares worth $1.77M. The position accounts for ﹤0.01% of the portfolio, ranked #2080.

Quantinno Capital Management first reported a position in RCUS in Q3 2025 and has held it in 4 quarters since. 231 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Quantinno Capital Management held 57,255 shares of Arcus Biosciences worth $1.77M as of Q2 2026.
  • Quantinno Capital Management bought 39,960 Arcus Biosciences shares in Q2 2026, an estimated $988K.
  • Arcus Biosciences made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #2080 holding.
  • Quantinno Capital Management first reported a position in Arcus Biosciences in Q3 2025 and has held it in 4 quarters since.
  • 231 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.